Z-1869-2014 Class II Terminated

Recalled by Elekta, Inc. — Atlanta, GA

FDA device recall Z-1869-2014 was initiated by Elekta, Inc. on May 29, 2014 and is designated Class II. Reason for recall: MOSAIQ does not re-calculate the agent volume when the user changes the ordering dose (to other than what was calculated) prior to saving the order. The recall status is terminated (terminated Jul 16, 2021). Affected quantity: 101.

Recall details

Product Type
Devices
Report Date
Jul 2, 2014
Initiation Date
May 29, 2014
Termination Date
Jul 16, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
101

Product description

MOSAIQ MOSAIQ is an oncology information system used to manage workflows for treatment planning and delivery. It supports information flow among healthcare facility personnel and can be used where ever radiotherapy and/or chemotherapy are prescribed.

Reason for recall

MOSAIQ does not re-calculate the agent volume when the user changes the ordering dose (to other than what was calculated) prior to saving the order.

Distribution pattern

Worldwide Distribution - USA (nationwide) including Puerto Rico and the states of AL, AK, AZ, CA, CO, CT, DE, FL, GA, HI, IL, IN, IA, KY, LA, ME, MD, MA, MI, MO, MT, NH, NJ, NM, NY, NC, ND, OH, OK, OR, PA, SC, SD, TX, VT, VA and WA,. and the countries of Australia, Canada, New Zealand and United Kingdom.

Code information

Released builds 2.50.04D5 and higher

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1869-2014
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1869-2014. Report a data issue: hello@regdatalab.com.